Apollo Hospitals shares hit 52-week high after strong Q4 FY26 earnings; from revenue to dividend, check all details

Apollo Hospitals Enterprise shares rallied 4% to hit their 52-week high of ₹8,388 per share on Thursday, May 21, as the company’s March quarter earnings boosted investors’ confidence.

The healthcare-providing firm reported a consolidated net profit of ₹529 crore on Wednesday for the fourth quarter of the financial year 2025-26 (Q4 FY26), marking an increase of 36% from ₹390 crore in the same period last year.

The company's revenue from operations grew 18% to ₹6,606 crore in the January-March quarter as compared to ₹5,592 crore in the corresponding quarter of the previous fiscal year.

The Chennai-headquartered company reported stable operational performance in the March quarter, as its earnings before interest, taxes, depreciation, and amortisation (EBITDA), also known as operating profit, advanced 31% to ₹1,011 crore as against ₹770 crore YoY.

Its operating profit margin expanded to 15.3% annually from 13.77%.

Apollo Health and Lifestyle also posted 24.2% revenue growth in the reporting quarter to ₹489.5 crore. Apollo HealthCo registered a revenue of ₹2,848.2 crore in Q4 FY26, marking a growth of 20%.

Dividend details

Apart from the earnings, the board of directors of Apollo Hospitals has also recommended a final dividend of ₹10 per equity share (200% of the face value of ₹5 per share) for the financial year 2025–26.

The dividend proposal is subject to approval by shareholders at the company’s upcoming Annual General Meeting (AGM) to be held on August 25, 2026.

Further, the board has fixed August 14, 2026, as the record date to determine the eligibility of shareholders for the final dividend as well as for participation in the AGM. The dividend, if declared at the AGM, will be paid on or before September 10, 2026.

Merger news

The board also approved the proposal for the merger of Apollo Hospitals North Limited (a wholly-owned subsidiary) into Apollo Hospitals Enterprise Ltd, subject to the receipt of necessary statutory approvals, the company said.

“The Board of Directors approved the proposal of the merger of M/s Apollo Hospitals North Limited (a wholly owned subsidiary) into Apollo Hospitals Enterprise Limited (the 'Holding Company' or the 'Company') subject to the receipt of necessary statutory approvals in accordance with the provisions of the Companies Act, 2013 through the National Company Law Tribunal route,” Apollo Hospitals said in a regulatory filing.

New transaction proposal

Furthermore, Apollo Health and Lifestyle Limited (AHLL) said it has entered into a combination for its Mother & Child and Fertility verticals, operated under “Apollo Cradle” and “Apollo Fertility”, with Kids Clinic India Limited’s corresponding businesses under the “Cloudnine” brand. The deal is aimed at creating one of India’s largest integrated maternity and fertility care platforms with a presence across key markets.

Post completion, AHLL will hold a 9.9% stake in the combined entity, making it the largest non-financial shareholder, and will also have board representation through a nominee director. The proposed transaction values AHLL’s standalone Mother & Child and Fertility verticals at ₹1,550 crore through a combination of cash and equity stake in the merged platform, the company said in a statement.

Apollo Hospitals share price

At 10:45 AM, shares of Apollo Hospitals were trading at ₹8,233.5 apiece on the National Stock Exchange, gaining 1.92%.

In a month, shares of the firm have jumped 6%, while for six months’ time, they have climbed over 11%. From the beginning of the year, Apollo Hospitals shares have rallied 16%.

The company has a market capitalisation stands at ₹1.18 lakh crore, according to NSE.